Safety and immunogenicity of recombinant low-dosage HIV-1 A vaccine candidates vectored by plasmid pTHr DNA or modified vaccinia virus Ankara (MVA) in humans in East Africa

Induction of Multifunctional Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T Cells Capable of Proliferation in Healthy Subjects by Using a Prime-Boost Regimen of DNA- and Modified Vaccinia Virus Ankara-Vectored Vaccines Expressing HIV-1 Gag Coupled to CD8⁺T-Cell Epitopes

Nilu Goonetilleke, S. S. Moore, Len Dally et al. · Journal of Virology · 2006 · 236 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Characterization of the Peptide Binding Motif of a Rhesus MHC Class I Molecule (Mamu-A*01) That Binds an Immunodominant CTL Epitope from Simian Immunodeficiency Virus

Todd M. Allen, John Sidney, Marie‐France del Guercio et al. · The Journal of Immunology · 1998 · 226 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humans

Matilu Mwau, Inese Cebere, Julian Sutton et al. · Journal of General Virology · 2004 · 210 citations

Life Sciences, Immunology, Infectious Diseases +17

Design and construction of an experimental HIV-1 vaccine for a year-2000 clinical trial in Kenya.

Tomáš Hanke, A J McMichael · Nature Medicine · 2000 · 196 citations

Veterinary Medicine, Immunology, Infectious Diseases +11

Improving Protective Immunity Induced by DNA-Based Immunization: Priming with Antigen and GM-CSF-Encoding Plasmid DNA and Boosting with Antigen-Expressing Recombinant Poxvirus

Martha Sedegah, Walter R. Weiss, John B. Sacci et al. · The Journal of Immunology · 2000 · 130 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17